ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2022 and some content may be unavailable. To unlock all content for 2022, please visit the archives.

Abstract: SA-PO219

Association of Vitamin D Levels and Bone Mineral Density in Elderly CKD Patients With Hip Fracture

Session Information

Category: Bone and Mineral Metabolism

  • 402 Bone and Mineral Metabolism: Clinical


  • Roy, Debajyoti M., Changi General Hospital, Singapore, Singapore
  • Ng, Chee Yong, Changi General Hospital, Singapore, Singapore
  • Yeon, Wenxiang, Changi General Hospital, Singapore, Singapore
  • Koduri, Sreekanth, Changi General Hospital, Singapore, Singapore

Vitamin D deficiency is common in chronic kidney disease (CKD) and is associated with lower bone mineral density (BMD), decreased muscle strength, and increased hip fracture risk. Guidelines have suggested optimal Vitamin D levels between 20-30ng/ml. However, Vitamin D metabolism is altered in CKD, and optimal levels are unknown.


We included 1097 patients with hip fractures. CKD was defined as estimated glomerular filtration rate <60ml/min/1.73m2, and low BMD defined as T score ≤-2.5 at femoral neck. We assessed the utility of using a 25-Vitamin D (25(OH)D) threshold of 30ng/dl, as well as a new threshold, to predict low BMD, in patients with, and without CKD.


CKD was present in 479 (44%) patients. Using threshold of 25(OH)D <30ng/ml. there was no significant differences in patients with CKD and low BMD, compared to the other groups. We identified 27ng/ml as a better threshold with the Youden index. Using 25(OH)D<27ng/ml as a threshold, 360 of 482 patients (74.7%) with low Vitamin D had low BMD, compared to only 185/276 (67%) of patients with adequate Vitamin D, p=0.02, which was irrespective of presence or absence of CKD. Furthermore, patients with CKD and 25(OH)D <27ng/ml had a higher odds ratio of mortality upon follow-up, 1.61, 95% CI: 1.08 – 2.39, compared to those with CKD and 25(OH)D≥ 27ng/ml.


Vitamin D <27ng/ml is associated with low BMD in patients with, and without, CKD. Further prospective studies targeting Vitamin D repletion to at least 27ng/ml, and outcome of hip fractures will be useful to validate these findings.